Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • pharma-news
    • Coronavirus: Zydus...

    Coronavirus: Zydus Wellness launches hand sanitizer under Nycil brand to meet growing demand

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2020-04-02T13:00:45+05:30  |  Updated On 2 April 2020 1:00 PM IST
    Coronavirus: Zydus Wellness launches hand sanitizer under Nycil brand to meet growing demand

    Nycil sanitizer consists of neem and aloevera extracts that helps kill 99.9 percent germs, Zydus Wellness said

    New Delhi: Zydus Group firm Zydus Wellness on Wednesday said it has forayed into hand sanitizer category with the launch of its product under the ''Nycil'' brand in the country to meet the rising demand due to COVID-19 outbreak.

    The company had acquired the Nycil brand as part of its acquisition of Heinz India.

    The company decided to roll out this product in a record time of 12 days, as a response to the current pandemic. Nycil sanitizer consists of neem and aloevera extracts that helps kill 99.9 percent germs, Zydus Wellness said.

    "We had acquired the Nycil brand as part of the acquisition of Heinz India. When we worked for the extension of the Nycil brand, one of the categories that came up was hand sanitizers. We had decided to launch this in 2021," Zydus Wellness CEO Tarun Arora told PTI.

    However, given the extraordinary times we are living in, the company decided to prepone the launch plans. As there is a need in the country for sanitizers, it was decided to launch it now, he added.

    "We are in a process of rolling it out across the country. This is the first-ever brand extension of Nycil. We have launched in the north, and as production ramps up we are in the process of scaling it to all parts of the country," Arora said.

    The company plans to roll out more than 2 million bottles on a priority basis in the next 30 days to be made available across India for medical help providers and general consumption, he added.

    When asked if the company is also looking at other brand extensions for Nycil, Arora replied in affirmative and said Zydus Wellness is looking at valuating the timing and preparations for it.

    On being asked if the company is also facing problems due to the nationwide lockdown, he said, "Right now we are also facing supply chain issues because of the lockdown, but the government is helping the industry to smoothen this process. It is a step in the right direction. Local governments are also helping the industry in this."

    The hand sanitizer is a permanent offering from the company and will continue to exist in the portfolio beyond the current situation, Zydus Wellness said.

    Read also: Zydus gets USFDA tentative nod for Carbidopa, Levodopa Extended-Release Capsules


    hand-sanitizerzyduszydus-wellnesscovid-19coronavirusnycil
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok